Mass Production of Paclitaxel by Plant Cell Culture

식물세포배양에 의한 항암제 Paclitaxel의 대랑 생산

  • 최형균 (삼양제넥스 생명공학연구소) ;
  • 손주선 (삼양제넥스 생명공학연구소) ;
  • 나광휘 (삼양제넥스 생명공학연구소) ;
  • 홍승서 (삼양제넥스 생명공학연구소) ;
  • 송재영 (삼양제넥스 생명공학연구소)
  • Published : 2002.04.01

Abstract

Samyang Genex succeeded in commercialization of anticancer agent-paclitaxel by plant cell culture technology. The core technology of Samyang Genex relating paclitaxel production includes cell line development, cell line preservation, cell culture, scale-up technology, and purification technology. On the basis of the research, Samyang Genex built the factory operated by CGMP (current good manufacturing practice). The $paclitaxel-Genexol^{TM}$ is commercially available in Korea, and it will be launched to world market including USA after approval US FDA.

Keywords